Clinical Trial Update: Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

View source ↗

Summary

This completed clinical trial update reports on the response rate and duration of response after stopping thrombopoietin receptor agonists in patients with prim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Immune Thrombocytopenia | Status: COMPLETED